B ACUTE LYMPHOBLASTIC LEUKEMIA

Clinical trials for B ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

Sign up with your email to follow new studies for B ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 11 Completed 1 Terminated 1

New CAR-T therapy targets hard-to-treat blood cancers after other options fail

Disease control Not yet recruiting

This early-phase study tests a new type of CAR-T cell therapy called Sup19 in 9 adults with B-cell blood cancers (like leukemia or lymphoma) that either stopped responding to previous CD19-targeted treatments or have low levels of the CD19 protein. The main goal is to check safet…

Matched conditions: B ACUTE LYMPHOBLASTIC LEUKEMIA

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 17, 2026 04:11 UTC

B ACUTE LYMPHOBLASTIC LEUKEMIA

Get alerted when new B ACUTE LYMPHOBLASTIC LEUKEMIA trials appear

New CAR-T therapy targets hard-to-treat blood cancers after other options fail